BusinessSANUWAVE Announces Exhibition at Wounds Canada 2018 Spring ConferenceBy Nasdaq OMXFeb 7, 2018, 1:32 PM UTC
BusinessSANUWAVE Health Appoints Orthopaedic and Podiatric Shockwave Executive, A. Michael Stolarski, to its BoardBy Nasdaq OMXApr 19, 2016, 1:00 PM UTC
BusinessSANUWAVE Health Reports 2015 Financial Results and Provides a Business UpdateBy Nasdaq OMXMar 30, 2016, 9:15 PM UTC
BusinessSANUWAVE Receives U.S. Patent for Novel Electrode Design to Increase Useful Life of Electrohydraulic Shock Wave DevicesBy Nasdaq OMXMar 29, 2016, 1:00 PM UTC
BusinessSANUWAVE Announces 24-Week Data From Its Pivotal Trials Investigating the Use of dermaPACE for the Treatment of Diabetic Foot UlcersBy Nasdaq OMXMar 24, 2016, 1:00 PM UTC
BusinessSANUWAVE Receives U.S. Patent for Special Reflectors Used for Applying Pressure Shock Waves in Various Medical TreatmentsBy Nasdaq OMXMar 17, 2016, 1:00 PM UTC
